‘Watch and Wait’ as Initial Management for Patients with Follicular Lymphomas-Reference-Cited by-同舟云学术

‘Watch and Wait’ as Initial Management for Patients with Follicular Lymphomas

Published:2012-12 Issue:6 Volume:26 Page:363-376
ISSN:1173-8804
Container-title:BioDrugs
language:en
Short-container-title:BioDrugs

Author:

Hagemeister Fredrick B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/BF03261894.pdf

Reference102 articles.

1. Portlock C, Rosenberg S. No initial therapy for stage III and IV non-Hodgkin’s lymphomas of favorable histologic types. Ann Intern Med 1979; 90: 10–3

2. Horning S, Rosenberg S. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med 1984; 311: 1471–5

3. Anderson T, DeVita V, Simon R, et al. Malignant lymphoma. II. Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer 1982; 50: 2708–21

4. Anderson T, Bender R, Fisher R, et al. Combination chemotherapy in non-Hodgkin’s lymphoma: results of long-term follow-up. Cancer Treat Rep 1977; 61: 1057–66

5. Rosenberg S. Non-Hodgkin’s lymphoma: selection of treatment on the basis of histologic type. N Engl J Med 1979; 30: 924–8

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy;British Journal of Haematology;2019-08-18

2. Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up;Journal of Clinical Oncology;2018-11-20

3. Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience;Advances in Therapy;2017-10

4. Follicular lymphoma: watch and wait is watch and worry;The Lancet Oncology;2014-04